Andrew Sas is an M.D. Ph.D. clinician scientist in neurology at the University of Michigan. Dr. Sas has NIH R25 funding to examine the inflammatory response after traumatic axonal injury under the mentorship of Dr. Segal. In the laboratory, his focus is on immunomodulation after traumatic neuronal injury to stimulate axon regeneration of neurons and improve recovery after optic nerve crush injury and traumatic spinal cord injury. His focus is on the recruitment and enhancement of neuroprotective and regenerative myeloid cells after neuronal injury.
Dr. Sas completed his M.D. and Ph.D. at the Medical University of South Carolina where he studied role of interferon alpha in the pathogenesis of HIV associated dementia. He completed his residency in neurology, and a clinical fellowship in sports neurology and traumatic brain injury at the University of Michigan, and sees traumatic brain injury patients in the clinic. The goal of his research is to find translational immunotherapy targets to promote healing after traumatic brain injury.